trending Market Intelligence /marketintelligence/en/news-insights/trending/lalBY0niVQLvgpcMN1Yfxg2 content esgSubNav
In This List

Vical enters research collaboration with AnGes MG

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Vical enters research collaboration with AnGes MG

Vical Inc. entered into a research collaboration agreement with AnGes MG Inc.

Under the agreement, AnGes agreed to provide funding for the program up to a specified limit, and Vical agreed to conduct certain preclinical research related to a development program targeting chronic hepatitis B.

In exchange for the payment, AnGes will receive an option to negotiate exclusive rights in Japan related to the program.

The companies also agreed to share the costs of prosecuting and maintaining intellectual property rights arising from the research program after such costs reach a specified limit.